The global market for Multiple Sclerosis Treatment Devices was valued at US$ 2739 million in the year 2024 and is projected to reach a revised size of US$ 5472 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Multiple Sclerosis Treatment Devices Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Multiple Sclerosis Treatment Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global multiple sclerosis treatment devices production reached appoximately 547,800 units, with an average global market price of around US$5,000 per unit. Multiple Sclerosis treatment utilizes a range of devices, including wearable and assistive technologies designed to manage symptoms like walking difficulties, muscle weakness, and fatigue, and to aid daily living.

North American market for Multiple Sclerosis Treatment Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Multiple Sclerosis Treatment Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Multiple Sclerosis Treatment Devices include Ypsomed AG, Owen Mumford Ltd, SHL Medical AG, Phillips-Medisize, Becton, Dickinson and Company, Nemera, Gerresheimer AG, Medtronic plc, Invacare Corporation, Hocoma AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Multiple Sclerosis Treatment Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Sclerosis Treatment Devices.

The Multiple Sclerosis Treatment Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiple Sclerosis Treatment Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multiple Sclerosis Treatment Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Multiple Sclerosis Treatment Devices Market Report

Report Metric	Details
Report Name	Multiple Sclerosis Treatment Devices Market
Accounted market size in year	US$ 2739 million
Forecasted market size in 2031	US$ 5472 million
CAGR	10.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Electrical Stimulation Devices Neurostimulation Devices Others
Segment by Application	Hospitals and Clinics Ambulatory Surgical Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ypsomed AG, Owen Mumford Ltd, SHL Medical AG, Phillips-Medisize, Becton, Dickinson and Company, Nemera, Gerresheimer AG, Medtronic plc, Invacare Corporation, Hocoma AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multiple Sclerosis Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multiple Sclerosis Treatment Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Multiple Sclerosis Treatment Devices Market growing?

Ans: The Multiple Sclerosis Treatment Devices Market witnessing a CAGR of 10.4% during the forecast period 2025-2031.

What is the Multiple Sclerosis Treatment Devices Market size in 2031?

Ans: The Multiple Sclerosis Treatment Devices Market size in 2031 will be US$ 5472 million.

Who are the main players in the Multiple Sclerosis Treatment Devices Market report?

Ans: The main players in the Multiple Sclerosis Treatment Devices Market are Ypsomed AG, Owen Mumford Ltd, SHL Medical AG, Phillips-Medisize, Becton, Dickinson and Company, Nemera, Gerresheimer AG, Medtronic plc, Invacare Corporation, Hocoma AG

What are the Application segmentation covered in the Multiple Sclerosis Treatment Devices Market report?

Ans: The Applications covered in the Multiple Sclerosis Treatment Devices Market report are Hospitals and Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Multiple Sclerosis Treatment Devices Market report?

Ans: The Types covered in the Multiple Sclerosis Treatment Devices Market report are Electrical Stimulation Devices, Neurostimulation Devices, Others

1 Multiple Sclerosis Treatment Devices Market Overview

1.1 Product Definition

1.2 Multiple Sclerosis Treatment Devices by Type

1.2.1 Global Multiple Sclerosis Treatment Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Electrical Stimulation Devices

1.2.3 Neurostimulation Devices

1.2.4 Others

1.3 Multiple Sclerosis Treatment Devices by Application

1.3.1 Global Multiple Sclerosis Treatment Devices Market Value by Application (2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Multiple Sclerosis Treatment Devices Market Size Estimates and Forecasts

1.4.1 Global Multiple Sclerosis Treatment Devices Revenue 2020-2031

1.4.2 Global Multiple Sclerosis Treatment Devices Sales 2020-2031

1.4.3 Global Multiple Sclerosis Treatment Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Multiple Sclerosis Treatment Devices Market Competition by Manufacturers

2.1 Global Multiple Sclerosis Treatment Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Multiple Sclerosis Treatment Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Multiple Sclerosis Treatment Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Multiple Sclerosis Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Product Type & Application

2.7 Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Date of Enter into This Industry

2.8 Global Multiple Sclerosis Treatment Devices Market Competitive Situation and Trends

2.8.1 Global Multiple Sclerosis Treatment Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Multiple Sclerosis Treatment Devices Players Market Share by Revenue

2.8.3 Global Multiple Sclerosis Treatment Devices Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Multiple Sclerosis Treatment Devices Market Scenario by Region

3.1 Global Multiple Sclerosis Treatment Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Multiple Sclerosis Treatment Devices Sales by Region: 2020-2031

3.2.1 Global Multiple Sclerosis Treatment Devices Sales by Region: 2020-2025

3.2.2 Global Multiple Sclerosis Treatment Devices Sales by Region: 2026-2031

3.3 Global Multiple Sclerosis Treatment Devices Revenue by Region: 2020-2031

3.3.1 Global Multiple Sclerosis Treatment Devices Revenue by Region: 2020-2025

3.3.2 Global Multiple Sclerosis Treatment Devices Revenue by Region: 2026-2031

3.4 North America Multiple Sclerosis Treatment Devices Market Facts & Figures by Country

3.4.1 North America Multiple Sclerosis Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Multiple Sclerosis Treatment Devices Sales by Country (2020-2031)

3.4.3 North America Multiple Sclerosis Treatment Devices Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Multiple Sclerosis Treatment Devices Market Facts & Figures by Country

3.5.1 Europe Multiple Sclerosis Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Multiple Sclerosis Treatment Devices Sales by Country (2020-2031)

3.5.3 Europe Multiple Sclerosis Treatment Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Multiple Sclerosis Treatment Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Multiple Sclerosis Treatment Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Multiple Sclerosis Treatment Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Multiple Sclerosis Treatment Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Multiple Sclerosis Treatment Devices Market Facts & Figures by Country

3.7.1 Latin America Multiple Sclerosis Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Multiple Sclerosis Treatment Devices Sales by Country (2020-2031)

3.7.3 Latin America Multiple Sclerosis Treatment Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Multiple Sclerosis Treatment Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Multiple Sclerosis Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Multiple Sclerosis Treatment Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Multiple Sclerosis Treatment Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Multiple Sclerosis Treatment Devices Sales by Type (2020-2031)

4.1.1 Global Multiple Sclerosis Treatment Devices Sales by Type (2020-2025)

4.1.2 Global Multiple Sclerosis Treatment Devices Sales by Type (2026-2031)

4.1.3 Global Multiple Sclerosis Treatment Devices Sales Market Share by Type (2020-2031)

4.2 Global Multiple Sclerosis Treatment Devices Revenue by Type (2020-2031)

4.2.1 Global Multiple Sclerosis Treatment Devices Revenue by Type (2020-2025)

4.2.2 Global Multiple Sclerosis Treatment Devices Revenue by Type (2026-2031)

4.2.3 Global Multiple Sclerosis Treatment Devices Revenue Market Share by Type (2020-2031)

4.3 Global Multiple Sclerosis Treatment Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Multiple Sclerosis Treatment Devices Sales by Application (2020-2031)

5.1.1 Global Multiple Sclerosis Treatment Devices Sales by Application (2020-2025)

5.1.2 Global Multiple Sclerosis Treatment Devices Sales by Application (2026-2031)

5.1.3 Global Multiple Sclerosis Treatment Devices Sales Market Share by Application (2020-2031)

5.2 Global Multiple Sclerosis Treatment Devices Revenue by Application (2020-2031)

5.2.1 Global Multiple Sclerosis Treatment Devices Revenue by Application (2020-2025)

5.2.2 Global Multiple Sclerosis Treatment Devices Revenue by Application (2026-2031)

5.2.3 Global Multiple Sclerosis Treatment Devices Revenue Market Share by Application (2020-2031)

5.3 Global Multiple Sclerosis Treatment Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ypsomed AG

6.1.1 Ypsomed AG Company Information

6.1.2 Ypsomed AG Description and Business Overview

6.1.3 Ypsomed AG Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ypsomed AG Multiple Sclerosis Treatment Devices Product Portfolio

6.1.5 Ypsomed AG Recent Developments/Updates

6.2 Owen Mumford Ltd

6.2.1 Owen Mumford Ltd Company Information

6.2.2 Owen Mumford Ltd Description and Business Overview

6.2.3 Owen Mumford Ltd Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Owen Mumford Ltd Multiple Sclerosis Treatment Devices Product Portfolio

6.2.5 Owen Mumford Ltd Recent Developments/Updates

6.3 SHL Medical AG

6.3.1 SHL Medical AG Company Information

6.3.2 SHL Medical AG Description and Business Overview

6.3.3 SHL Medical AG Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 SHL Medical AG Multiple Sclerosis Treatment Devices Product Portfolio

6.3.5 SHL Medical AG Recent Developments/Updates

6.4 Phillips-Medisize

6.4.1 Phillips-Medisize Company Information

6.4.2 Phillips-Medisize Description and Business Overview

6.4.3 Phillips-Medisize Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Phillips-Medisize Multiple Sclerosis Treatment Devices Product Portfolio

6.4.5 Phillips-Medisize Recent Developments/Updates

6.5 Becton, Dickinson and Company

6.5.1 Becton, Dickinson and Company Company Information

6.5.2 Becton, Dickinson and Company Description and Business Overview

6.5.3 Becton, Dickinson and Company Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Becton, Dickinson and Company Multiple Sclerosis Treatment Devices Product Portfolio

6.5.5 Becton, Dickinson and Company Recent Developments/Updates

6.6 Nemera

6.6.1 Nemera Company Information

6.6.2 Nemera Description and Business Overview

6.6.3 Nemera Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Nemera Multiple Sclerosis Treatment Devices Product Portfolio

6.6.5 Nemera Recent Developments/Updates

6.7 Gerresheimer AG

6.7.1 Gerresheimer AG Company Information

6.7.2 Gerresheimer AG Description and Business Overview

6.7.3 Gerresheimer AG Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Gerresheimer AG Multiple Sclerosis Treatment Devices Product Portfolio

6.7.5 Gerresheimer AG Recent Developments/Updates

6.8 Medtronic plc

6.8.1 Medtronic plc Company Information

6.8.2 Medtronic plc Description and Business Overview

6.8.3 Medtronic plc Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Medtronic plc Multiple Sclerosis Treatment Devices Product Portfolio

6.8.5 Medtronic plc Recent Developments/Updates

6.9 Invacare Corporation

6.9.1 Invacare Corporation Company Information

6.9.2 Invacare Corporation Description and Business Overview

6.9.3 Invacare Corporation Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Invacare Corporation Multiple Sclerosis Treatment Devices Product Portfolio

6.9.5 Invacare Corporation Recent Developments/Updates

6.10 Hocoma AG

6.10.1 Hocoma AG Company Information

6.10.2 Hocoma AG Description and Business Overview

6.10.3 Hocoma AG Multiple Sclerosis Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Hocoma AG Multiple Sclerosis Treatment Devices Product Portfolio

6.10.5 Hocoma AG Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Multiple Sclerosis Treatment Devices Industry Chain Analysis

7.2 Multiple Sclerosis Treatment Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Multiple Sclerosis Treatment Devices Production Mode & Process Analysis

7.4 Multiple Sclerosis Treatment Devices Sales and Marketing

7.4.1 Multiple Sclerosis Treatment Devices Sales Channels

7.4.2 Multiple Sclerosis Treatment Devices Distributors

7.5 Multiple Sclerosis Treatment Devices Customer Analysis

8 Multiple Sclerosis Treatment Devices Market Dynamics

8.1 Multiple Sclerosis Treatment Devices Industry Trends

8.2 Multiple Sclerosis Treatment Devices Market Drivers

8.3 Multiple Sclerosis Treatment Devices Market Challenges

8.4 Multiple Sclerosis Treatment Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Becton Dickinson and Company

List of Tables

Table 1. Global Multiple Sclerosis Treatment Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Multiple Sclerosis Treatment Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Multiple Sclerosis Treatment Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Multiple Sclerosis Treatment Devices Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Multiple Sclerosis Treatment Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Multiple Sclerosis Treatment Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Multiple Sclerosis Treatment Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Multiple Sclerosis Treatment Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Multiple Sclerosis Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Product Type & Application

Table 12. Global Key Manufacturers of Multiple Sclerosis Treatment Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Multiple Sclerosis Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Multiple Sclerosis Treatment Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Multiple Sclerosis Treatment Devices Sales by Region (2020-2025) & (Units)

Table 18. Global Multiple Sclerosis Treatment Devices Sales Market Share by Region (2020-2025)

Table 19. Global Multiple Sclerosis Treatment Devices Sales by Region (2026-2031) & (Units)

Table 20. Global Multiple Sclerosis Treatment Devices Sales Market Share by Region (2026-2031)

Table 21. Global Multiple Sclerosis Treatment Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Multiple Sclerosis Treatment Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Multiple Sclerosis Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Multiple Sclerosis Treatment Devices Sales by Country (2020-2025) & (Units)

Table 27. North America Multiple Sclerosis Treatment Devices Sales by Country (2026-2031) & (Units)

Table 28. North America Multiple Sclerosis Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Multiple Sclerosis Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Multiple Sclerosis Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Multiple Sclerosis Treatment Devices Sales by Country (2020-2025) & (Units)

Table 32. Europe Multiple Sclerosis Treatment Devices Sales by Country (2026-2031) & (Units)

Table 33. Europe Multiple Sclerosis Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Multiple Sclerosis Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Multiple Sclerosis Treatment Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Multiple Sclerosis Treatment Devices Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Multiple Sclerosis Treatment Devices Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Multiple Sclerosis Treatment Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Multiple Sclerosis Treatment Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Multiple Sclerosis Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Multiple Sclerosis Treatment Devices Sales by Country (2020-2025) & (Units)

Table 42. Latin America Multiple Sclerosis Treatment Devices Sales by Country (2026-2031) & (Units)

Table 43. Latin America Multiple Sclerosis Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Multiple Sclerosis Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Multiple Sclerosis Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Multiple Sclerosis Treatment Devices Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Multiple Sclerosis Treatment Devices Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Multiple Sclerosis Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Multiple Sclerosis Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Multiple Sclerosis Treatment Devices Sales (Units) by Type (2020-2025)

Table 51. Global Multiple Sclerosis Treatment Devices Sales (Units) by Type (2026-2031)

Table 52. Global Multiple Sclerosis Treatment Devices Sales Market Share by Type (2020-2025)

Table 53. Global Multiple Sclerosis Treatment Devices Sales Market Share by Type (2026-2031)

Table 54. Global Multiple Sclerosis Treatment Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Multiple Sclerosis Treatment Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Type (2020-2025)

Table 59. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Type (2026-2031)

Table 60. Global Multiple Sclerosis Treatment Devices Sales (Units) by Application (2020-2025)

Table 61. Global Multiple Sclerosis Treatment Devices Sales (Units) by Application (2026-2031)

Table 62. Global Multiple Sclerosis Treatment Devices Sales Market Share by Application (2020-2025)

Table 63. Global Multiple Sclerosis Treatment Devices Sales Market Share by Application (2026-2031)

Table 64. Global Multiple Sclerosis Treatment Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Multiple Sclerosis Treatment Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Multiple Sclerosis Treatment Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Application (2020-2025)

Table 69. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Application (2026-2031)

Table 70. Ypsomed AG Company Information

Table 71. Ypsomed AG Description and Business Overview

Table 72. Ypsomed AG Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Ypsomed AG Multiple Sclerosis Treatment Devices Product

Table 74. Ypsomed AG Recent Developments/Updates

Table 75. Owen Mumford Ltd Company Information

Table 76. Owen Mumford Ltd Description and Business Overview

Table 77. Owen Mumford Ltd Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Owen Mumford Ltd Multiple Sclerosis Treatment Devices Product

Table 79. Owen Mumford Ltd Recent Developments/Updates

Table 80. SHL Medical AG Company Information

Table 81. SHL Medical AG Description and Business Overview

Table 82. SHL Medical AG Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. SHL Medical AG Multiple Sclerosis Treatment Devices Product

Table 84. SHL Medical AG Recent Developments/Updates

Table 85. Phillips-Medisize Company Information

Table 86. Phillips-Medisize Description and Business Overview

Table 87. Phillips-Medisize Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Phillips-Medisize Multiple Sclerosis Treatment Devices Product

Table 89. Phillips-Medisize Recent Developments/Updates

Table 90. Becton, Dickinson and Company Company Information

Table 91. Becton, Dickinson and Company Description and Business Overview

Table 92. Becton, Dickinson and Company Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Becton, Dickinson and Company Multiple Sclerosis Treatment Devices Product

Table 94. Becton, Dickinson and Company Recent Developments/Updates

Table 95. Nemera Company Information

Table 96. Nemera Description and Business Overview

Table 97. Nemera Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Nemera Multiple Sclerosis Treatment Devices Product

Table 99. Nemera Recent Developments/Updates

Table 100. Gerresheimer AG Company Information

Table 101. Gerresheimer AG Description and Business Overview

Table 102. Gerresheimer AG Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Gerresheimer AG Multiple Sclerosis Treatment Devices Product

Table 104. Gerresheimer AG Recent Developments/Updates

Table 105. Medtronic plc Company Information

Table 106. Medtronic plc Description and Business Overview

Table 107. Medtronic plc Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Medtronic plc Multiple Sclerosis Treatment Devices Product

Table 109. Medtronic plc Recent Developments/Updates

Table 110. Invacare Corporation Company Information

Table 111. Invacare Corporation Description and Business Overview

Table 112. Invacare Corporation Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Invacare Corporation Multiple Sclerosis Treatment Devices Product

Table 114. Invacare Corporation Recent Developments/Updates

Table 115. Hocoma AG Company Information

Table 116. Hocoma AG Description and Business Overview

Table 117. Hocoma AG Multiple Sclerosis Treatment Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Hocoma AG Multiple Sclerosis Treatment Devices Product

Table 119. Hocoma AG Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Multiple Sclerosis Treatment Devices Distributors List

Table 123. Multiple Sclerosis Treatment Devices Customers List

Table 124. Multiple Sclerosis Treatment Devices Market Trends

Table 125. Multiple Sclerosis Treatment Devices Market Drivers

Table 126. Multiple Sclerosis Treatment Devices Market Challenges

Table 127. Multiple Sclerosis Treatment Devices Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Multiple Sclerosis Treatment Devices

Figure 2. Global Multiple Sclerosis Treatment Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Multiple Sclerosis Treatment Devices Market Share by Type: 2024 & 2031

Figure 4. Electrical Stimulation Devices Product Picture

Figure 5. Neurostimulation Devices Product Picture

Figure 6. Others Product Picture

Figure 7. Global Multiple Sclerosis Treatment Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Multiple Sclerosis Treatment Devices Market Share by Application: 2024 & 2031

Figure 9. Hospitals and Clinics

Figure 10. Ambulatory Surgical Centers

Figure 11. Others

Figure 12. Global Multiple Sclerosis Treatment Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Multiple Sclerosis Treatment Devices Market Size (2020-2031) & (US$ Million)

Figure 14. Global Multiple Sclerosis Treatment Devices Sales (2020-2031) & (Units)

Figure 15. Global Multiple Sclerosis Treatment Devices Average Price (US$/Unit) & (2020-2031)

Figure 16. Multiple Sclerosis Treatment Devices Report Years Considered

Figure 17. Multiple Sclerosis Treatment Devices Sales Share by Manufacturers in 2024

Figure 18. Global Multiple Sclerosis Treatment Devices Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Multiple Sclerosis Treatment Devices Players: Market Share by Revenue in Multiple Sclerosis Treatment Devices in 2024

Figure 20. Multiple Sclerosis Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Multiple Sclerosis Treatment Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Multiple Sclerosis Treatment Devices Sales Market Share by Country (2020-2031)

Figure 23. North America Multiple Sclerosis Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 24. United States Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Multiple Sclerosis Treatment Devices Sales Market Share by Country (2020-2031)

Figure 27. Europe Multiple Sclerosis Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 28. Germany Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Multiple Sclerosis Treatment Devices Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Multiple Sclerosis Treatment Devices Revenue Market Share by Region (2020-2031)

Figure 35. China Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Multiple Sclerosis Treatment Devices Sales Market Share by Country (2020-2031)

Figure 43. Latin America Multiple Sclerosis Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Multiple Sclerosis Treatment Devices Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Multiple Sclerosis Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Multiple Sclerosis Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Multiple Sclerosis Treatment Devices by Type (2020-2031)

Figure 54. Global Revenue Market Share of Multiple Sclerosis Treatment Devices by Type (2020-2031)

Figure 55. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Multiple Sclerosis Treatment Devices by Application (2020-2031)

Figure 57. Global Revenue Market Share of Multiple Sclerosis Treatment Devices by Application (2020-2031)

Figure 58. Global Multiple Sclerosis Treatment Devices Price (US$/Unit) by Application (2020-2031)

Figure 59. Multiple Sclerosis Treatment Devices Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Autism Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9T16706

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ADHD Planner App Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34C16185

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Autism Digital Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2E16662

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25A16539

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions